References
1. Elliott AD, Middeldorp ME, Van Gelder IC, Albert CM, Sanders P. Epidemiology and modifiable risk factors for atrial fibrillation.Nat Rev Cardiol. 2023;20(6):404-417.
2. Ko D, Rahman F, Schnabel RB, Yin X, Benjamin EJ, Christophersen IE. Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol. 2016;13(6):321-332.
3. Volgman AS, Bairey Merz CN, Benjamin EJ, et al. Sex and Race/Ethnicity Differences in Atrial Fibrillation. J Am Coll Cardiol. 2019;74(22):2812-2815.
4. Cho L, Davis M, Elgendy I, et al. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review. J Am Coll Cardiol.2020;75(20):2602-2618.
5. Clayton JA, Gaugh MD. Sex as a Biological Variable in Cardiovascular Diseases: JACC Focus Seminar 1/7. J Am Coll Cardiol.2022;79(14):1388-1397.
6. Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation.2023.
7. Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1261-1274.
8. Ko D, Rahman F, Martins MA, et al. Atrial fibrillation in women: treatment. Nat Rev Cardiol. 2017;14(2):113-124.
9. Cheng X, Hu Q, Gao L, Liu J, Qin S, Zhang D. Sex-related differences in catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Europace. 2019;21(10):1509-1518.
10. du Fay de Lavallaz J, Badertscher P, Kobori A, et al. Sex-specific efficacy and safety of cryoballoon versus radiofrequency ablation for atrial fibrillation: An individual patient data meta-analysis.Heart Rhythm. 2020;17(8):1232-1240.
11. Yadav R, Milstein J, Blum J, et al. Sex-based differences in safety and efficacy of catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2023;34(8):1640-1647.
12. Kloosterman M, Chua W, Fabritz L, et al. Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5.Europace. 2020;22(7):1026-1035.
13. Zylla MM, Brachmann J, Lewalter T, et al. Sex-related outcome of atrial fibrillation ablation: Insights from the German Ablation Registry. Heart Rhythm. 2016;13(9):1837-1844.
14. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498.
15. Rong B, Han W, Lin M, et al. Thromboembolic Risk of Cessation of Oral Anticoagulation Post Catheter Ablation in Patients With and Without Atrial Fibrillation Recurrence. Am J Cardiol. 2020;137:55-62.
16. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.Eur Heart J. 2016;37(38):2893-2962.
17. Kistler PM, Chieng D, Sugumar H, et al. Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial.JAMA. 2023;329(2):127-135.
18. Chen H, Li C, Han B, et al. Circumferential Pulmonary Vein Isolation With vs Without Additional Low-Voltage-Area Ablation in Older Patients With Paroxysmal Atrial Fibrillation: A Randomized Clinical Trial.JAMA Cardiol. 2023;8(8):765-772.
19. Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713-1723.
20. Kirchhof P, Camm AJ, Goette A, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med.2020;383(14):1305-1316.
21. Kim SR, Bae S, Lee JY, et al. Gender disparities in prevalence by diagnostic criteria, treatment and mortality of newly diagnosed acute myocardial infarction in Korean adults. Sci Rep. 2023;13(1):4120.
22. Buhari H, Fang J, Han L, et al. Stroke risk in women with atrial fibrillation. Eur Heart J. 2024;45(2):104-113.
23. Gerdts E, Regitz-Zagrosek V. Sex differences in cardiometabolic disorders. Nat Med. 2019;25(11):1657-1666.
24. Emdin CA, Wong CX, Hsiao AJ, et al. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ.2016;532:h7013.
25. Zeitler EP, Kearing S, Coylewright M, et al. Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex. Circulation. 2023;147(7):586-596.
26. Deng H, Shantsila A, Guo P, et al. Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry. Arch Cardiovasc Dis.2019;112(3):171-179.
27. Ma Y, Guo L, Liu C, Xu J, Wang Y, Yi F. Sex differences in paroxysmal atrial fibrillation catheter ablation: A difference-in-difference propensity score matched analysis. Pacing Clin Electrophysiol. 2023;46(8):969-977.
28. Jie QQ, Li G, Duan JB, et al. Remodeling of myocardial energy and metabolic homeostasis in a sheep model of persistent atrial fibrillation. Biochem Biophys Res Commun. 2019;517(1):8-14.
29. Nattel S, Guasch E, Savelieva I, et al. Early management of atrial fibrillation to prevent cardiovascular complications. Eur Heart J. 2014;35(22):1448-1456.
30. Masuda M, Matsuda Y, Uematsu H, et al. Gender Differences in Atrial Fibrosis and Cardiomyopathy Assessed by Left Atrial Low-Voltage Areas During Catheter Ablation of Atrial Fibrillation. Am J Cardiol.2023;203:37-44.
31. Van Gelder IC, Ekrami NK, Borof K, et al. Sex Differences in Early Rhythm Control of Atrial Fibrillation in the EAST-AFNET 4 Trial. J Am Coll Cardiol. 2023;81(8):845-847.
32. Kang DS, Kim D, Jang E, et al. Sex Difference in Effectiveness of Early Rhythm- over Rate-Control in Patients with Atrial Fibrillation.J Clin Med. 2022;11(17).